Nawa Lodin is an associate in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where she is a member of the firm’s digital health industry group and healthcare practice. She advises healthcare, digital health, life sciences, and technology companies on complex healthcare regulatory and transactional matters, with a particular focus on artificial intelligence and machine learning in healthcare, telehealth, corporate practice of medicine, and federal and state fraud and abuse laws, including the Anti-Kickback Statute and Stark Law.

Nawa regularly serves as healthcare regulatory counsel on complex mergers and acquisitions, strategic investments, venture and growth equity financings, and capital markets transactions involving healthcare regulatory diligence, transaction structuring, and risk allocation issues. She also advises clients on the rapidly evolving landscape of state healthcare transaction review and healthcare antitrust notification laws, including filing obligations, structuring considerations, and timing implications affecting healthcare transactions, MSOs, provider organizations, payors, and digital health companies. Her capital markets experience includes representing issuers and underwriters in numerous healthcare public offerings and debt financings.

Nawa was recently recognized by Bloomberg Law as one of its “40 Under 40” in healthcare. Prior to joining the firm, Nawa was an associate at Simpson Thacher & Bartlett LLP and Goodwin Procter LLP. She serves on the board of directors of Women for Afghan Women, one of the world’s largest Afghan women’s rights organizations, and is fluent in Dari.